Excitement at lapatinib and trastuzumab combination's ground-breaking …

Excitement at lapatinib and trastuzumab combination's ground-breaking …

The finding that around a quarter of woman with HER2 positive breast cancer who were treated with lapatinib and trastuzumab saw their tumors shrink or disappear has 'ground-breaking' potential, an expert has said. Women in the clinical trial, who had

(Visited 3 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.